Summary
Quest Diagnostics Incorporated filed an 8-K report on October 19, 2006, to announce its financial results for the third quarter and the first nine months of 2006. This filing primarily incorporates by reference a press release that details the company's operational performance and financial condition for the period ending September 30, 2006. While the 8-K itself does not contain the specific financial figures, it directs investors to the attached press release (Exhibit 99.1) for comprehensive details on revenue, earnings, and other key performance indicators. Investors interested in Quest Diagnostics' performance during this period should refer to that press release for a thorough understanding of the reported financial outcomes.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on October 19, 2006.
- 2The filing announced results for the quarter and nine months ended September 30, 2006.
- 3The primary purpose of the 8-K was to furnish financial results, as per Item 2.02.
- 4A press release containing the detailed financial results is attached as Exhibit 99.1.
- 5This exhibit is incorporated by reference into the 8-K filing.
- 6The Chief Financial Officer, Robert A. Hagemann, signed the report.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce Quest Diagnostics' financial results for the third quarter and the first nine months of 2006, ending September 30, 2006.
The detailed financial results are not directly included in the 8-K filing itself. They are provided in a press release, which is attached as Exhibit 99.1 to this filing and incorporated by reference.
The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.
The announced financial results cover the third quarter of 2006 and the first nine months of 2006, both ending on September 30, 2006.